BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18042733)

  • 1. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
    Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
    Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
    Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression.
    Vore M; Leggas M
    Mol Pharmacol; 2008 Mar; 73(3):613-5. PubMed ID: 18086804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.
    Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G
    Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.
    Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G
    Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.
    Ee PL; He X; Ross DD; Beck WT
    Mol Cancer Ther; 2004 Dec; 3(12):1577-83. PubMed ID: 15634651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
    Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
    Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
    Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells.
    Brayman MJ; Julian J; Mulac-Jericevic B; Conneely OM; Edwards DP; Carson DD
    Mol Endocrinol; 2006 Oct; 20(10):2278-91. PubMed ID: 16740655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
    Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
    Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
    Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
    Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
    Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
    Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells.
    Goldman S; Lovett DH; Shalev E
    Reprod Biol Endocrinol; 2009 May; 7():41. PubMed ID: 19426551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
    Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
    Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.